Here's the live share price of Aarti Pharmalabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Aarti Pharmalabs has gained 17.54% CAGR. Over the past year, the corresponding return has been 32.65%.
Aarti Pharmalabs’s current P/E of 28.95x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aarti Pharmalabs | 2.25 | 2.57 | -6.72 | 20.34 | 33.42 | 31.16 | 17.67 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Aarti Pharmalabs has gained 33.42% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Aarti Pharmalabs has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 838.56 | 835.7 |
| 10 | 838.77 | 836.66 |
| 20 | 833.63 | 840.5 |
| 50 | 855.03 | 852.3 |
| 100 | 876.58 | 848.41 |
| 200 | 805.82 | 806.15 |
In the latest quarter, Aarti Pharmalabs saw a drop in promoter holding to 42.90%, while DII stake decreased to 6.95%, FII holding rose to 8.02%, and public shareholding moved up to 42.12% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 67,500 | 0.02 | 5.59 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 27, 2025, 10:07 PM IST | Aarti Pharmalabs - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Standalone And Consolidate |
| Oct 14, 2025, 12:46 AM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Oct 08, 2025, 4:27 PM IST | Aarti Pharmalabs - Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or R |
| Oct 07, 2025, 11:55 PM IST | Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 24, 2025, 1:24 AM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation |
Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1771.35 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aarti Pharmalabs is ₹850.90 as on Oct 31, 2025.
The Aarti Pharmalabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Aarti Pharmalabs is ₹7,713.18 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Aarti Pharmalabs are ₹860.00 and ₹831.65.
The 52-week high/low is the highest and lowest price at which Aarti Pharmalabs stock has traded in the past 52-week or nearly a year. The 52-week high of Aarti Pharmalabs is ₹971.50 and 52-week low of Aarti Pharmalabs is ₹550.25 as on Oct 31, 2025.
The Aarti Pharmalabs has shown returns of 1.36% over the past day, 1.98% for the past month, -7.26% over 3 months, 32.65% over 1 year, 30.9% across 3 years, and 17.54% over 5 years.
P/E ratio of and PB ratio of Aarti Pharmalabs are 28.95 and 4.15 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.